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Abstract
 
Differentiation of naive CD4
 
 
 
 T cells into helper T (Th) cells is controlled by a combination of
several transcriptional factors. In this study, we examined the functional role of the Runx1
transcription factor in Th cell differentiation. Naive T cells from transgenic mice expressing a
dominant interfering form of Runx1 exhibited enhanced interleukin 4 production and efficient
 
Th2 differentiation. In contrast, transduction of Runx1 into wild-type T cells caused a complete
 
attenuation of Th2 differentiation and was accompanied by the cessation of 
 
GATA3
 
 expression.
Furthermore, endogenous expression of Runx1 in naive T cells declined after T cell receptor
stimulation, at the same time that expression of GATA3 increased. We conclude that Runx1
plays a novel role as a negative regulator of 
 
GATA3
 
 expression, thereby inhibiting the Th2
cell differentiation.
Key words: GATA3 • Runx1 • Th2 • T lymphocytes • transcription factor
 
Introduction
 
When encountering antigens, naive CD4
 
 
 
 T cells in peripheral
lymphoid tissues differentiate into mature Th cells and secrete a
large amount of effector cytokines. Th cells are categorized into
two functionally distinct subsets based on their cytokine secre-
 
tion characteristics (1). Th1 cells produce IL-2, IFN-
 
 
 
, and tu-
mor necrosis factor 
 
 
 
. These cytokines act on macrophages and
mediate their effector functions, such as eradication of intracel-
lular organisms and organ-specific autoreactive immune re-
sponses. Th2 cells produce IL-4, IL-5, IL-6, IL-10, and IL-13,
which act on B cells and regulate their humoral immune re-
sponse against extracellular pathogens (2–4).
Expression of cytokine genes in a Th1- versus Th2-lin-
eage-specific fashion is strictly regulated by the coordina-
tion of both lineage-specific and nonspecific transcription
factors. Naive cells require signaling via TCRs and CD28
molecules in conjunction with signaling via the IL-4 re-
ceptor (IL-4R) to differentiate into Th2 cell (5, 6). TCR
stimulation initiates the expression of a Th2-specific tran-
scription factor, c-Maf (7, 8), and induces the nuclear
translocation of NFAT (9). IL-4R–mediated signaling
promotes the phosphorylation and subsequent nuclear
translocation of STAT6, which in turn triggers the expres-
sion of 
 
GATA3
 
 (10). GATA3 is a key transcription factor
that regulates the expression of the entire set of Th2 cyto-
kine genes (11). For example, ectopic expression of
GATA3 can, even in the absence of IL-4–mediated
STAT6 activation, induce chromatin remodeling at the
 
IL-4
 
 locus as well as expression of other Th2 cytokine
genes (12–14). Furthermore, the expressed GATA3 pro-
tein auto-activates 
 
GATA3
 
 transcription (13, 14). These
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effects of GATA3 ensure full commitment of cells to the
Th2 lineage.
The Runx1 transcription factor, also known as acute
myelogenous leukemia protein 1 (AML1) and core binding
factor 
 
 
 
2 (CBF
 
 
 
2), harbors a 128-amino-acid region
which is homologous to the 
 
Drosophila
 
 gene products Runt
and Lozenge. This region is termed the Runt domain and
is responsible for both DNA binding and hetero-dimeriza-
tion with its partner protein, PEBP2
 
 
 
/CBF
 
 
 
 (15, 16). Of
clinical significance is that several chromosomal rearrange-
ments involving 
 
Runx1
 
 are associated with the occurrence
of human acute myelogenous leukemia (17). Furthermore,
gene targeting studies have revealed that the homozygous
deletion of 
 
Runx1
 
 
 
severely impairs the development of a
definitive type of hematopoiesis, thereby causing the em-
bryonic lethality (18–20). Thus, Runx1 is involved in leu-
kemogenesis and hematopoietic development (21–23).
We previously established several lines of transgenic
mice in which we artificially modulated Runx1 activity,
and used them to show that Runx1 is also involved in var-
ious aspects of T cell differentiation in the thymus (24, 25).
In the current study, we examined the functional relevance
of Runx1 in helper–T cell differentiation. We have found
that Runx1 by itself can repress 
 
GATA3
 
 expression and
Th2 differentiation of CD4
 
 
 
 T cells.
 
Materials and Methods
 
Mice.
 
Transgenic mouse lines expressing the Runt domain of
the murine Runx1 protein were established as described previ-
ously (24). Litters possessing the transgene were backcrossed with
C57BL/6J mice for seven generations. Mice targeted for 
 
IL-4R
 
were provided by F. Brombacher, Univ. Cape Town, Cape
Town, Republic of South Africa (26). Establishment of mouse
lines expressing 
 
GATA3
 
 as a transgene will be described else-
where (unpublished data). C57BL/6J and BALB/c mice were
purchased from Kumagai Co. Ltd. and Sankyo Inc., respectively.
 
Cell Culture.
 
Cells were liberated from the spleens of mice
and suspended in PBS. The single cell suspension was overlaid
onto Lymphosepar II (IBL) and centrifuged at 400 
 
g
 
 for 20 min at
room temperature. The lymphocyte fraction was collected and
incubated with DynaBeads Mouse CD4 (L3T4; Dynal). The
CD4
 
 
 
 T cells were then dissociated from the beads by the use of
DETACHaBEAD Mouse CD4 (Dynal). The CD4
 
 
 
 fraction ob-
tained was more than 95% pure as judged by flow cytometrical
analysis. The cells were suspended in RPMI 1640 medium con-
taining 10% (vol/vol) FCS, 10 mM HEPES-KOH, pH 7.4, 2
mM 
 
l
 
-glutamine, and 50 
 
 
 
M 2-mercaptoethanol, and subjected
to culture in a 48-well plate at a density of 2 
 
 
 
 10
 
5
 
 cells/500 
 
 
 
l
medium in each well.
For TCR stimulation, the cells were cultured in a plate that
was coated beforehand with 10 
 
 
 
g/ml of an anti-CD3 antibody
(145–2C11) and 10 
 
 
 
g/ml of anti-CD28 antibody (37.51; BD
Biosciences) according to the previously described procedure
(27). In some cases, the TCR-stimulated cells were cultured in
the presence of 30 U/ml of IL-2 for 5 d.
To induce cells to differentiate toward the Th2 lineage, the
cells were cultured in the presence of 4 
 
 
 
g/ml of anti–IFN-
 
 
 
 anti-
body (UBI) and 100 U/ml of murine IL-4 (PeproTech), together
with the precoated anti-CD3/anti-CD28 antibodies. For Th1 dif-
 
ferentiation, the cells were cultured in the presence of 4 
 
 
 
g/ml of
anti-IL-4 antibody (UBI) and 5 ng/ml of murine IL-12 (Pepro-
Tech), together with the precoated anti-CD3/anti-CD28 anti-
bodies. After 4 d of culture, the cells were washed with fresh me-
dia, replated at a cell density of 2 
 
 
 
 10
 
5
 
 in a well precoated with
anti-CD3/anti-CD28 antibodies and incubated for a further 24 h.
To assess the degree of cell proliferation, the cells were incu-
bated with 1 
 
 
 
Ci/well 
 
3
 
H-thymidine for 6 h. The incorporation
of 
 
3
 
H-thymidine into a 5% (wt/vol) trichloroacetic acid-insoluble
fraction of cells was counted with a liquid scintillation counter.
 
Retrovirus Infection.
 
The cDNAs of murine 
 
Runx1
 
 (28),
 
Runx2
 
 (29), and 
 
Runx3
 
 (AF155880, GenBank/EMBL/DDBJ)
were inserted into a pMX-green fluorescent protein (GFP)
 
*
 
 vector
(30). To ensure that Runx1 (or its related protein) and GFP were
translated bi-cistronically, an internal ribosomal entry site was li-
gated upstream of the GFP. In case, 
 
Runx1
 
 was inserted into a
pMX-rat CD2 vector and 
 
GATA3
 
 into pMX-GFP. Each of the
resulting plasmids was transfected into a packaging cell line, PLAT-T,
using FuGENE6 (Roche) and, after incubation for 24 h, the cul-
ture supernatant was harvested and condensed as a viral stock.
The CD4
 
 
 
 T cells were stimulated by anti-CD3/anti-CD28
antibodies for 24 h. The cells were then infected with retrovirus
in the presence of 0.5 
 
 
 
g/ml of polybrene for 24 h and cultured
further in the presence of 30 U/ml of IL-2 for 5 d. In some cases,
100 U/ml of IL-4 was added to the medium together with the
IL-2. The cells were washed with fresh media and restimulated
by anti-CD3/anti-CD28 antibodies for 6 h for intracellular cy-
tokine staining and for 24 h for the cytokine production assay.
 
Flow Cytometrical Analysis.
 
The single cell suspensions were
first incubated with an anti-Fc receptor antibody (24G2) and then
stained with appropriately diluted monoclonal antibodies. The
fluorescein-conjugated antibodies used were as follows: anti-CD4
PE (H129.19), anti-CD4 FITC (RM4–5), anti-CD8a FITC (53–
6.7), anti-CD8a PE (53–6.7), anti-TCR
 
 
 
 FITC (H57–597),
anti-CD25 FITC (7D4), and anti-CD69 FITC (H1.2F3). The
anti-CD4 PE was purchased from Sigma-Aldrich and all the
other antibodies were purchased from BD Biosciences. Anti-IL-
4R
 
 
 
 (M1) was provided by Immunex.
To detect intracellular IL-4 and IFN-
 
 
 
, the cells were restimu-
lated by anti-CD3/anti-CD28 antibodies and incubated in the
presence of 2 
 
 
 
M monensin (Sigma-Aldrich) for 6 h. The cells
were then fixed with 4% (wt/vol) paraformaldehyde in PBS and
permeabilized in a solution containing 50 mM NaCl, 5 mM
EDTA, 0.02% (wt/vol) NaN
 
3
 
, pH 7.5, and 0.5% (wt/vol) Triton
X-100. After blocking with PBS containing 3% (wt/vol) BSA, the
cells were stained with anti–IFN-
 
 
 
 FITC (XMG1.2) and anti–
IL-4 PE (11B11). Flow cytometry was performed using a FACS-
Calibur™ and the data were analyzed using a CELLQuest™ soft-
ware (Becton Dickinson). In some cases, the GFP
 
 
 
 or rat CD2
 
 
 
population was sorted using a FACSVantage™. Anti-rat CD2 PE
(LFA-2) was purchased from Cedarlane.
 
ELISA.
 
The amount of cytokines secreted in the tissue cul-
ture supernatant was assayed by ELISA. Kits supplied from Bio-
source International were used to detect IL-2, IL-4, IL-5, IL-10,
and IFN-
 
 
 
.
 
Immunoblot Analysis and EMSA.
 
All the procedures necessary
for immunoblot analysis were performed as described previously
(6). Anti-Jak1, anti-STAT6, anti-phosphorylated STAT6, and
anti-phosphotyrosine antibodies were purchased from Upstate
Biotechnology, Sigma-Aldrich, New England Biolabs, Inc., and
Covance Research Products, Inc., respectively. Anti-Ikaros (M-20)
 
*
 
Abbreviation used in this paper
 
: GFP, green fluorescent protein.T
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and anti-GATA3 (HG3–31) antibodies were obtained from Santa
Cruz Biotechnology, Inc. and anti-Runx1 antibody from
Geneka. The protocol of EMSA was as described previously (31).
 
Northern Blot Analysis.
 
Total cytoplasmic RNA was isolated
from cells using a TRIzol reagent (GIBCO BRL). 2 
 
 
 
g of RNA
was separated on a 1% (wt/vol) agarose gel containing 2.2 M
formaldehyde. Transfer of RNA onto a Hybond N membrane
(Amersham Biosciences), hybridization, and washing were per-
formed according to the procedure supplied by the manufacturer
(Roche). The probes used were digoxigenin-labeled antisense-
riboprobes transcribed from the cDNA template of 
 
T-bet
 
, 
 
GATA3
 
,
and 
 
G3PDH.
 
 Signals were visualized using an alkaline phos-
phatase-conjugated, anti-digoxigenin antibody (Roche).
 
Results
 
A Dominant Interfering Form of Runx1 Promotes Th2 Cell
Differentiation.
 
We previously established mouse lines that
express a DNA binding domain of Runx1 from a transgene
 
in a T-lineage-specific way (24). This Runt domain is
known to function in a dominant interfering fashion against
the Runx1 protein that is expressed endogenously in T lym-
phocytes. In the present study, we investigated the role of
the Runx1 transcription factor in Th cell differentiation us-
ing these Runt-transgenic mice. Naive CD4
 
 
 
 T cells were
isolated from the spleens of wild-type and Runt-transgenic
mice and stimulated with anti-CD3/anti-CD28 antibodies.
The culture supernatants were collected and the amount of
cytokines secreted was measured by ELISA (Fig. 1 A). The
Runt-transgenic cells produced five times as much IL-4 as
the wild-type cells at 72 h after incubation. Similarly, the
Runt-transgenic cells produced 1.7 and 3.4 times as much
IL-5 and IL-10, respectively, as the wild-type cells. The
Runt-transgenic cells thus exhibited enhanced production of
Th2–type cytokines during an early phase of TCR activa-
tion. In contrast, secretion of IFN-
 
 
 
 and IL-2 from the
Runt-transgenic cells was decreased slightly and markedly,
Figure 1. Production of Th2- and Th1-
type cytokines from wild-type and Runt-
transgenic CD4  T cells. (A) Naive CD4 
T cells were isolated from the spleens of
wild-type and Runt–transgenic mice and
stimulated with anti-CD3/anti-CD28 anti-
bodies, and the culture supernatants were
collected at the indicated times after stimu-
lation. (B) The TCR-stimulated cells were
cultured in the presence of IL-2 for 5 d,
washed with fresh media, and restimulated
via TCR. The culture supernatants were
collected after 24 h. (C) The cells were cul-
tured for four days in the Th2- or Th1-
inducing condition. The cells were washed
with fresh media and restimulated via TCR.
The culture supernatants were collected af-
ter 24 h. (D) Same as C, but note the differ-
ence of scale used in C and here. The
amounts of cytokines secreted into the su-
pernatants were measured by ELISA and
their averages and standard deviations are
shown. Data are representative of four inde-
pendent experiments.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
 
54
 
Runx1 Inhibits the Th2 Differentiation
 
respectively, compared with the wild-type cells. A similar
result as that shown in Fig. 1 A was obtained when the
TCR-stimulated cells were incubated in the presence of
IL-2 for 5 d, washed with fresh media, and restimulated via
TCR (Fig. 1 B). Under this neutral culture condition where
neither IL-4 nor IL-12 was added to media, the Runt-trans-
genic cells secreted several fold more amount of Th2-type
cytokines and less amount of Th1-type cytokines than the
wild-type cells.
We next examined the cytokine production from the
Runt-transgenic cells under culture conditions that favor
either Th1 or Th2 differentiation. CD4
 
 
 
 T cells were stim-
ulated with anti-CD3/anti-CD28 antibodies and incubated
in the presence of either IL-4 and an anti-IFN-
 
 
 
 antibody
(Th2 condition) or IL-12 and an anti-IL-4 antibody (Th1
condition) for 4 d. Cells were washed with fresh media and
restimulated via TCR, and cytokine secretion was mea-
sured (Fig. 1 C). In the Th2 condition, the Runt-trans-
genic cells produced eight times as much IL-4 as the wild-
type cells. In contrast, in the Th1 condition, although IFN-
 
 
 
production from the Runt-transgenic cells was reduced
compared with the wild-type cells, IL-4 production from
the Runt-transgenic cells did not reach the level of 10 to
100 ng/ml concentration. Thus, the Runt-expressing cells
effectively differentiate into the Th2 lineage in a Th2- but
not a Th1-favorable environment.
It must be pointed here that, even in the Th1 condition,
the Runt-transgenic cells actually produced 25 times as
much IL-4 as the wild-type cells (Fig. 1 D). The absolute
amount of IL-4 secreted from the Runt-transgenic cells
was, however, 5 ng/ml in the Th1 condition (Fig. 1 D) in-
stead of 120 ng/ml in the Th2 condition (Fig. 1 C). There-
fore, the Runt-transgenic cells, though showing a Th2 ten-
dency to some degree, could not have differentiated
effectively into the Th2 lineage under the Th1 condition.
 
Overexpression of Runx1 Prevents Naive Cells from Differen-
tiating Into the Th2 Lineage.
 
If reducing the effect of
Runx1 with the Runt transgene induces Th2 differentia-
tion, as shown in Fig. 1, we wondered whether the artifi-
cial overexpression of Runx1 protein in naive T cells
would cause a decrease in Th2 differentiation. CD4
 
 
 
 T
cells were stimulated with anti-CD3/anti-CD28 antibod-
ies and infected by retroviruses that harbor either pMX or
pMX-Runx1. The former vector encodes GFP only, and
the latter encodes both GFP and Runx1. The cells were
incubated in the presence of IL-2 and restimulated via
TCR, and the profile of cytokine production was assessed
by intracellular staining of cytokines followed by flow cy-
tometry (Fig. 2 A). In pMX-infected cells, 71% of GFP
 
 
 
cells were IL-4 positive. In contrast, the percentage of IL-
4–producing cells in the pMX-Runx1-infected population
was drastically decreased to 5% of GFP
 
 
 
 cells. However,
the proportion of IFN-
 
 
 
 producing cells markedly in-
creased with pMX-Runx1 infection compared with pMX
infection. We also examined the effect of Runx1 expres-
sion on the secretion of other Th2-type cytokines. The
GFP
 
 
 
 cells were sorted after retrovirus infection and the
amount of IL-5 and IL-10 secreted was measured (Fig. 2
B). Overexpression of Runx1 strikingly reduced the
amount of IL-5 and IL-10. The overexpression of Runx1
thus inhibits the production of Th2-type cytokines in
Figure 2. Effect of Runx1 overexpression on the production of various
cytokines. (A) Naive CD4  T cells were isolated from the spleens of
BALB/c mice, stimulated with anti-CD3/anti-CD28 antibodies, and in-
fected by retroviruses carrying pMX or pMX-Runx1. After culture in the
presence of IL-2, the cells were washed and reactivated via TCR, and
processed for flow cytometrical analysis of intracellular IL-4, IFN- , and
GFP. The numbers represent the percentages of cells in each quadrant.
(B) The GFP  population was sorted after retrovirus infection and reacti-
vated via TCR. The amount of cytokines secreted into the culture superna-
tant was measured by ELISA. Data are representative of four independent
experiments. (C) Immunoblot analysis of Runx1 protein. The GFP  and
GFP  populations were sorted from the pMX-Runx1–infected cells. The
nuclear fractions were prepared from each population and their protein
extracts were processed for immunoblot analysis using anti-Runx1 and
anti-Ikaros antibodies, respectively.T
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TCR-stimulated cells in a neutral cytokine environment.
Immunoblot analysis detects the Runx1 protein in the
cDNA-transduced, GFP  fraction but scarcely in the non-
transduced, GFP  fraction out of pMX-Runx1-infected
cells (Fig. 2 C). The effects seen in Fig. 2, A and B, are
thus considered to be due to the exogenously expressed
Runx1 protein.
We next examined whether overexpression of Runx1 is
inhibitory for Th2-cell differentiation even in a Th2-favor-
able cytokine environment. CD4  T cells were stimulated
with anti-CD3/anti-CD28 antibodies, infected by retrovi-
ruses, and cultured in the presence or absence of an exces-
sive amount of exogenously added IL-4. The cells were re-
stimulated via TCR and analyzed for cytokine production
using flow cytometry (Fig. 3 A). In the pMX-infected cells,
addition of IL-4 increased the ratio of IL-4  cells among
the GFP  population as expected. IL-4 production was
much lower in the Runx1-overexpressing cells than in the
pMX-infected cells, and IL-4 supplementation did not re-
store IL-4 production in these cells. The amount of cyto-
kines secreted from the GFP  population was also measured
by ELISA (Fig. 3 B). Addition of IL-4 enhanced the secre-
tion of both IL-4 and IL-5 from the pMX-infected cells. In
the Runx1-overexpressing cells, however, production of
IL-4 and IL-5 did not recover even after addition of IL-4.
Thus, the overexpression of Runx1 can block TCR-stim-
ulated CD4  cells from differentiating into the Th2 lineage
even under a Th2-favorable culture condition and this in-
hibitory effect of Runx1 on Th2 differentiation is not due
to the paucity of IL-4 itself.
It must be noted that the IL-4-containing medium sup-
plies cells with a condition unfavorable to Th1 differentia-
tion. In both the pMX- and pMX-Runx1–infected cells,
the percentage of IFN- -positive cells as well as the
amount of secreted IL-2 decreased in response to the addi-
tion of IL-4.
Overexpression of Runx1 Does Not Impair TCR and IL-4R
Signaling During Th Differentiation. As overexpression of
Runx1 prevented cells from differentiating into Th2 cells,
we examined whether Runx1 affects the TCR and IL-4R
Figure 3. Effect of IL-4 supple-
mentation on the production of vari-
ous cytokines from Runx1-trans-
duced cells. (A) Naive CD4  T cells
were isolated from the spleens of
BALB/c mice, stimulated with anti-
CD3/anti-CD28 antibodies and in-
fected by retroviruses carrying pMX
or pMX-Runx1. After culture in the
presence of IL-2 alone or of both
IL-2 and IL-4, the cells were
washed, reactivated via TCR, and
processed for flow cytometrical
analysis of intracellular IL-4, IFN- ,
and GFP. The numbers represent the
percentages of cells in each quadrant.
(B) The GFP  population was sorted
from the retrovirus-infected cells and
reactivated via TCR. The amount of
cytokines secreted into the culture
supernatant was measured by ELISA.
Data are representative of two inde-
pendent experiments.T
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signaling pathways. We used flow cytometry to analyze cell
surface molecules such as the TCR  chain, CD4, CD25,
CD69, and IL-4R  (Fig. 4 A). The expression profiles of
these molecules in the GFP  fractions were comparable in
the pMX- and pMX-Runx1-infected cells. To analyze sig-
naling molecules further, protein was extracted from the
GFP  population and processed for immunoblot analysis
(Fig. 4 B). The amounts of Jak1 and STAT6 were not af-
fected by overexpression of Runx1 nor by supplementa-
tion with IL-4. Phosphorylation of a 125-kD protein (in-
dicated in Fig. 4 B by the bottom arrow) was induced by
the addition of IL-4 and likely represents Jak1 and Jak3.
The degree of phosphorylation of this 125-kD protein was
comparable in pMX- and pMX-Runx1–infected cells.
Phosphorylation of STAT6 was also induced by IL-4 to a
similar degree in both the pMX- and pMX-Runx1–
infected cells. Thus, overexpression of Runx1 is not likely
to affect the IL-4R signaling pathway, at least not through
the phosphorylation of STAT6. It must be noted also that
overexpression of Runx1 was not inhibitory for IL-4–
Figure 4. Effect of Runx1 overexpression
on TCR- and IL-4R- signaling. (A) Naive
CD4  T cells were isolated from the spleens
of BALB/c mice, stimulated with anti-
CD3/anti-CD28 antibodies, and infected
by retroviruses carrying pMX or pMX-
Runx1. After culture in the presence of
IL-2, the cells were washed, reactivated via
TCR, and processed for flow cytometrical
analysis. The red lines represent fluores-
cence emitted from antibody-stained cells,
whereas the gray lines represent fluores-
cence from cells stained by control IgG. (B)
The GFP  population was sorted from the
retrovirus-infected cells and cultured in the
absence or presence of IL-4. In the left
panel, protein was extracted at 10 min after
the addition of IL-4, whereas, in the right
panel, protein was extracted at 10, 30, and
60 min after the IL-4 addition. The extract
was processed for immunoblot analysis us-
ing anti-Jak1, anti-STAT6, anti-phosphoty-
rosine, and anti-phosphorylated STAT6-
specific antibodies. The bands indicated by
the bottom arrow probably correspond to
phosphorylated Jak1/Jak3, whereas the
bands indicated by the top arrow probably
represent phosphorylated IRS1/IRS2. (C)
Naive CD4  T cells were TCR-stimulated,
infected by retroviruses, and cultured in the
presence of IL-2 alone or of both IL-2 and
the indicated concentration of IL-4. The
GFP  population was sorted and incubated
in the presence of 3H-thymidine. The in-
corporation of radioactivity into an acid-
insoluble fraction of the cells was measured.
Data are representative of two independent
experiments.T
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dependent cell proliferation. Different concentrations of IL-4
were added to the medium and incorporation of 3H-thy-
midine into an acid-insoluble fraction of the cells was mea-
sured (Fig. 4 C). The pMX-Runx1-infected cells prolifer-
ated rather better than the pMX-infected cells.
Runx1 Negatively Regulates Th2 Differentiation of Cells by
Inhibiting GATA3 Expression. The GATA3 transcription
factor is located downstream of IL-4R signaling pathway
and regulates the commitment of cells toward the Th2 lin-
eage (11). We therefore examined whether overexpression
of Runx1 affects GATA3 expression. The RNA was ex-
tracted from the GFP  fractions and processed for North-
ern blot analysis (Fig. 5 A). In the pMX-infected cells,
some amount of GATA3 transcript was detected (lane 1),
whereas almost no GATA3 transcript was detected in the
pMX-Runx1–infected cells (lane 3). Furthermore, addition
of an excess amount of IL-4 into the medium induced
higher expression of GATA3 in the pMX-infected cells
(lane 2), but could not restore GATA3 expression in the
Runx1-overexpressing cells (lane 4). The amount of T-bet,
a Th1-specific transcription factor (32), decreased in re-
sponse to the addition of IL-4 in both the Runx1-overex-
pressing and pMX-infected cells (lanes 2 and 4). Thus,
Runx1 can strongly repress the induction of GATA3 ex-
pression and the inability of Runx1-overexpressing cells to
differentiate into the Th2 lineage is likely due to this pau-
city of GATA3 induction.
We further examined the degree of GATA3 expression
in the Runt-transgenic cells. CD4  T cells were stimulated
by anti-CD3/anti-CD28 antibodies and the extracted
RNA was processed for Northern blot analysis (Fig. 5 B).
The GATA3 transcript was detected in the Runt-trans-
genic cells at a significantly higher level (1.5 to 2.0 fold in-
crease) than in the wild-type cells. The result thus suggests
that the effective differentiation of Runt-transgenic cells
into the Th2 lineage under the neutral as well as Th2 con-
ditions (Fig. 1, A–C) is likely attributable to the up-regula-
tion of GATA3 expression.
It must be noted that expression of GATA3 was
blocked in both the wild-type and Runt-transgenic cells
by adding an anti-IL-4 antibody (Fig. 5 B), indicating that
GATA3 expression is dependent on IL-4R signaling. A
difference between the two types of cells is, however,
clearly visible when the TCR-stimulated cells were incu-
bated in the presence of IL-12 (a lower portion of Fig. 5
B). The Runt-transgenic cells expressed twice as much
GATA3 transcript as the wild-type cells, though to a lesser
degree compared with the absence of IL-12. Thus, in the
case of Runt-transgenic cells, a feature of GATA3 expres-
sion in the presence of IL-12 (Fig. 5 B) appears to be in
accordance with the profile of IL-4 production in the Th1
condition (Fig. 1 D).
Forced Expression of GATA3 Relieves the Inhibitory Effect
of Runx1 on Th2 Differentiation. We next examined
whether GATA3 transduction could recover Th2 cytokine
production in the pMX-Runx1–infected cells, using
GATA3-transgenic mice. CD4  T cells were prepared
from wild-type and transgenic mice, stimulated by anti-
CD3/anti-CD28 antibodies, and infected by pMX or
pMX-Runx1 retroviruses. The GFP  cells were sorted and
restimulated via TCR, and the amounts of secreted cyto-
Figure 5. Effect of Runx1 overexpression and Runt-transgene on
GATA3 expression. (A) Naive CD4  T cells were isolated from the
spleens of BALB/c mice, stimulated with anti-CD3/anti-CD28 antibod-
ies, and infected by retroviruses carrying pMX or pMX-Runx1. After
culture in the presence of IL-2 alone or of both IL-2 and IL-4, the cells
were washed and reactivated via TCR. The GFP  population was sorted
as shown in the top panel, and RNA was extracted and processed for
Northern blot analysis as shown in the lower panel. (B) Naive CD4  T
cells were isolated from the spleens of wild-type and Runt-transgenic
mice, and stimulated with anti-CD3/anti-CD28 antibodies. In case, ei-
ther anti–IL-4 antibody or IL-4 or IL-12 was added to the culture me-
dium as indicated. RNA was extracted and processed for Northern blot
analysis. Relative intensity of GATA3 and T-bet transcripts that were
normalized by that of G3PDH are shown below the lanes. Data are rep-
resentative of two independent experiments.T
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kines were assayed. In Fig. 6 A, the values obtained for the
pMX-Runx1-infected cells are presented as percent inhibi-
tion of secretion, taking the values obtained for the pMX-
infected cells to be 100%. The percent inhibition of IL-4
and IL-5 secretion in the GATA3-transgenic cells was
roughly two thirds and one half of that in the wild-type
cells, respectively. GATA3 did not cause a significant dif-
ference in the IFN-  production of the wild-type and
transgenic cells.
We also tried cotransduction of GATA3 and Runx1 into
CD4  T cells. In this particular case, the cells were pre-
pared from the IL-4R ( / ) mice so that it becomes pos-
sible to evaluate the effects of introduced genes indepen-
dently from IL-4R signaling. The TCR-stimulated cells
were doubly infected by pMX-GFP and pMX-rat CD2
retroviruses each of which harbors (or not) GATA3 or
Runx1 as indicated (Fig. 6 B). The rat CD2 positive cells
were sorted, restimulated via TCR and processed for intra-
cellular staining of IL-4. Both the GATA3-solely-express-
ing and GATA3/Runx1-coexpressing cells showed a sig-
nificant increase in the IL-4 positive fraction, compared
with the cells not introduced by GATA3. The results in
Fig. 6, A and B, thus indicate that forced expression of
GATA3 can, at least partially, compensate for the inhibi-
tory effect of Runx1 on Th2 differentiation.
Expression of Runx1 in Naive CD4  T Cells Is Down-regu-
lated after TCR Stimulation. Runx1, when overexpressed,
can negatively regulate GATA3 expression. To explore a
relationship between Runx1 and GATA3 under a physio-
logical condition, we first examined the expression pattern
of endogenous proteins in naive CD4 , Th2, and Th1 cells
by immunoblot analysis (Fig. 7 A). The Runx1 protein was
evident as a 56-kD band in naive CD4  cells, but not in
fully differentiated Th1 cells for 7 d. In Th2 cells, a subtle
amount of Runx1 protein might be present. Therefore,
Runx1 appears to play its role, if any, in naive but not in
differentiated Th1 nor Th2 cells.
We then examined the profile of protein expression dur-
ing an early phase of TCR activation (Fig. 7 B). At 12 and
24 h after TCR stimulation, the level of Runx1 was mark-
edly decreased in both the Th2- and Th1-culturing condi-
tions. Concomitantly, expression of GATA3 was induced
in a Th2-condition. The extract was also processed for
EMSA using a Runx-binding oligonucleotide as a probe
(Fig. 7 C). DNA/protein complexes containing Runx1 or
a Runx1/CBF  heterodimer (33) were detected in the naive
CD4  cells but not in the cells treated by anti-CD3/anti-
CD28 antibodies for 24 h. Thus, the results in Fig. 7, B and
C, indicate that the TCR stimulation of naive CD4  T
cells causes down-regulation of Runx1 protein and simul-
Figure 6. Effect of cotransduction of
GATA3 and Runx1 on Th2 cell differentia-
tion. (A) Naive CD4  T cells were isolated
from the spleens of wild-type and GATA3-
transgenic mice, TCR-stimulated, infected
by retroviruses carrying pMX or pMX-
Runx1, and cultured in the presence of IL-2.
The GFP  population was sorted and reac-
tivated via TCR. The cytokines secreted
into the culture supernatant were measured
by ELISA. The values obtained for the
pMX-Runx1–infected cells are presented as
percent inhibition of secretion, taking the
values observed for the pMX-infected cells
to be 100%. (B) Naive CD4  T cells were
isolated from the spleens of IL-4R ( / )
mice, TCR-stimulated, coinfected by
pMX-GFP and pMX-rat CD2 retroviruses
as indicated, and cultured in the presence of
IL-2. The rat CD2  population was sorted,
TCR-stimulated, and processed for flow
cytometrical analysis of intracellular IL-4.
Data are representative of two independent
experiments.T
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taneous induction of GATA3 protein during the early
phase of activation. 
We finally evaluated the degree of Runx1 overexpres-
sion in the retrovirus-infection experiments described
above. The intensity of 56-kD band in the pMX-Runx1–
infected cells was roughly twice as dense as that in naive
CD4  cells (Fig. 7 A). In addition, the endogenous and ex-
ogenous 56-kD bands turned out to comigrate in parallel,
indicating the band to represent the authentic Runx1 pro-
tein. Thus, the amount of exogenously introduced Runx1
protein is roughly similar with that expressed endogenously
in naive CD4  T cells.
Discussion
In this study, we showed that transduction of a dominant
interfering form of Runx1 in peripheral CD4  T cells re-
sulted in a marked and coordinate production of IL-4, IL-
5, and IL-10 following TCR stimulation. Overexpression
of Runx1, on the other hand, attenuated Th2-cell differen-
tiation and led to the cessation of GATA3 expression. This
inhibitory effect of Runx1 on Th2 differentiation could
not be reversed by supplementation with an excess amount
of IL-4, but was, at least partially, relieved by the forced
expression of GATA3 itself. Thus, the Runx1 transcription
factor functions as a negative regulator for Th2-cell differ-
entiation by inhibiting GATA3 expression.
Various transcription factors have been reported to be
involved in the regulation of Th2 differentiation (34).
Among them, GATA3 is considered to be a crucial factor,
as it directly controls chromatin remodeling of the IL-4 lo-
cus (13, 14). GATA3 expression occurs as two distinct
phases: a transient initial phase that is dependent on IL-4–
mediated STAT6 function (10), and a GATA3-dependent
auto-activation phase (13, 14). Recently, repressor of
GATA (ROG) and friend of GATA1 (FOG1) were shown
to bind to GATA3 and were thereby characterized as
GATA3-repressing proteins (35, 36). Expression of ROG
and FOG1 is transiently detected within 24 to 48 h after
primary T cell activation and is detected regardless of
whether the conditions are skewed toward Th1 or Th2.
Thus, these two factors conceivably participate in the regu-
lation of GATA3-dependent auto-activation in order to
prevent the excessive production of Th2 cytokines. It must
be noted that the expression pattern of Runx1 in the early
activation phase is distinct from that of ROG and FOG1.
Runx1 is significantly expressed in the wild-type, CD4  T
cells but rapidly decreases after TCR activation. Given that
the inhibitory effect of Runx1 on GATA3 expression
could not be reversed by adding an excess amount of IL-4,
it is conceivable that Runx1 negatively regulates the
GATA3 expression in an IL-4R–independent fashion.
Thus, in the case of naive T cells, TCR-mediated down-
regulation of Runx1 may be a first step or a prerequisite for
initiating expression of GATA3. In contrast to naive cells,
Runx1 was not detected or detected only in a subtle
amount in differentiated Th1 or Th2 cells. Therefore,
Runx1 appears to play its role mainly in naive CD4  cells
and during the early phase of TCR activation but not in
differentiation-completed Th cells.
On the other hand, as seen in transgenic mice, reduction
of endogenous Runx1 activity by Runt leads to the exces-
Figure 7. Expression of endogenous Runx1 and GATA3 proteins in
CD4  T cells. (A) Naive CD4  T cells were isolated from the spleens of
mice and cultured under the Th1- or Th2-condition for 7 d. Protein ex-
tracts were processed for immunoblot analysis, using anti-Runx1 antibody.
Protein extracted from the pMX-Runx1-infected or pMX-infected,
TCR-stimulated CD4  T cells was also probed with the same antibody.
(B) Protein was extracted at indicated hour after culturing in the Th2- or
Th1-condition. (C) Naive CD4  T cells were treated or not by anti-
CD3/anti-CD28 antibodies for 24 h. Extracts containing 1, 3, and 5  g
protein, respectively, were processed for EMSA. Data are representative
of two independent experiments.T
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
60 Runx1 Inhibits the Th2 Differentiation
sive production of Th2-type cytokines under the neutral
and Th2-favorable conditions. This suggests that Runx1
may also play an additional role so as to prevent cells from
overwhelmingly differentiating into the Th2 lineage. It
must be noted that the Runt-transgenic cells did not fully
differentiate into the Th2 lineage under the Th1 culturing
condition, as seen by their magnitude of IL-4 production
and GATA3 expression. Thus, IL-4 signaling appears to be
necessary for the Runt-transgenic cells to fully commit to
the Th2 lineage. Considering how Runx1 affects GATA3
expression, the above situation may not be unreasonable.
Runx1 can be a repressor of GATA3 expression and func-
tions during an initial phase of TCR-stimulation of naive
cells. The Runt domain, which acts as a dominant negative
factor against the endogenous Runx1 protein, therefore
could cancel only the repressive activity of Runx1 on
GATA3, but not positively enhance GATA3 expression.
The function of Runx1 as a transcription factor differs
depending on its interaction with different types of cofac-
tors. On one hand, Runx1 functions as a transcriptional ac-
tivator of hematopoiesis-related genes such as GM-CSF
(37), IL-3 (38), and the TCR  chain (39, 40). In these
cases, Runx1 interacts with a coactivator, p300/CBP (41),
which has histone acetyltransferase activity. On the other
hand, Runx1 can also behave as a transcriptional repressor
through interaction with a corepressor (42), and one possi-
bility is that Runx1 represses GATA3 expression by di-
rectly binding to its regulatory region. The conserved
COOH-terminal pentapeptide, VWRPY, in the Runx1
protein is a binding site for a corepressor, Groucho/TLE
(43, 44). The transducion of a series of deletion mutants
demonstrated that the COOH-terminal region including
this VWRPY motif is responsible for the inhibitory effect
of Runx1 on Th2 differentiation (unpublished data). How-
ever, as the VWRPY motif is conserved among all three
Runx proteins, and the inhibition of IL-4 production is a
characteristic feature of Runx1 but not of Runx2 nor of
Runx3 (unpublished data), it is unlikely that the GATA3
repression by Runx1 is simply mediated by recruiting
Groucho/TLE. Moreover, an alternative possibility that
cannot be excluded is that Runx1 is indirectly involved in
repressing GATA3 expression by regulating other factor(s)
such as Mel-18 (45) and NF- B (46). Further analysis is re-
quired to elucidate the precise mechanism by which
Runx1 represses GATA3 expression. A possibility is not
excluded either that Runx1 is also involved in the regula-
tion of IL-4 transcription itself.
We express our sincere thanks to the following scientists for pro-
viding us with their valuable experimental tools: T. Kitamura for
the pMX-GFP vector, F. Brombacher for IL-4R targeted mice, and
D. Levanon and Y. Groner for the murine Runx3 cDNA. We also
thank M. Kuji for her secretarial assistance.
This work was supported by research grants from the Ministry of
Education, Science, Sports, Culture and Technology, Japan.
Submitted: 16 July 2002
Revised: 2 April 2003
Accepted: 15 April 2003
References
1. Mosmann, T.R., H. Cherwinski, M.W. Bond, M.A. Gied-
lin, and R.L. Coffman. 1986. Two types of murine helper T
cell clone. I. Definition according to profiles of lymphokine
activities and secreted proteins. J. Immunol. 136:2348–2357.
2. Paul, W.E., and R.A. Seder. 1994. Lymphocyte responses
and cytokines. Cell. 76:241–251.
3. O’Garra, A. 1998. Cytokines induce the development of
functionally heterogeneous T helper cell subsets. Immunity.
8:275–283.
4. Glimcher, L.H., and K.M. Murphy. 2000. Lineage commit-
ment in the immune system: the T helper lymphocyte grows
up. Genes Dev. 14:1693–1711.
5. Thompson, C.B. 1995. Distinct roles for the costimulatory
ligands B7-1 and B7-2 in T helper cell differentiation? Cell.
81:979–982.
6. Kubo, M., M. Yamashita, R. Abe, T. Tada, K. Okumura,
J.T. Ransom, and T. Nakayama. 1999. CD28 costimulation
accelerates IL-4 receptor sensitivity and IL-4-mediated Th2
differentiation. J. Immunol. 163:2432–2442.
7. Ho, I.C., M.R. Hodge, J.W. Rooney, and L.H. Glimcher.
1996. The proto-oncogene c-maf is responsible for tissue-
specific expression of interleukin-4. Cell. 85:973–983.
8. Ho, I.C., D. Lo, and L.H. Glimcher. 1998. c-maf promotes
T helper cell type 2 (Th2) and attenuates Th1 differentiation
by both interleukin 4-dependent and -independent mecha-
nisms. J. Exp. Med. 188:1859–1866.
9. Flanagan, W.M., B. Corthesy, R.J. Bram, and G.R. Crab-
tree. 1991. Nuclear association of a T-cell transcription factor
blocked by FK-506 and cyclosporin A. Nature. 352:803–807.
10. Kurata, H., H.J. Lee, A. O’Garra, and N. Arai. 1999. Ectopic
expression of activated Stat6 induces the expression of Th2-
specific cytokines and transcription factors in developing Th1
cells. Immunity. 11:677–688.
11. Zheng, W., and R.A. Flavell. 1997. The transcription factor
GATA-3 is necessary and sufficient for Th2 cytokine gene
expression in CD4 T cells. Cell. 89:587–596.
12. Ferber, I.A., H.J. Lee, F. Zonin, V. Heath, A. Mui, N. Arai,
and A. O’Garra. 1999. GATA-3 significantly downregulates
IFN-  production from developing Th1 cells in addition to
inducing IL-4 and IL-5 levels. Clin. Immunol. 91:134–144.
13. Lee, H.J., N. Takemoto, H. Kurata, Y. Kamogawa, S.
Miyatake, A. O’Garra, and N. Arai. 2000. GATA-3 induces
T helper cell type 2 (Th2) cytokine expression and chromatin
remodeling in committed Th1 cells. J. Exp. Med. 192:105–
115.
14. Ouyang, W., M. Lohning, Z. Gao, M. Assenmacher, S.
Ranganath, A. Radbruch, and K.M. Murphy. 2000. Stat6-
independent GATA-3 autoactivation directs IL-4-indepen-
dent Th2 development and commitment. Immunity. 12:27–
37.
15. Kagoshima, H., K. Shigesada, M. Satake, Y. Ito, H. Miyoshi,
M. Ohki, M. Pepling, and P. Gergen. 1993. The Runt do-
main identifies a new family of heteromeric transcriptional
regulators. Trends Genet. 9:338–341.
16. Meyers, S., J.R. Downing, and S.W. Hiebert. 1993. Identifi-
cation of AML-1 and the (8;21) translocation protein (AML-
1/ETO) as sequence-specific DNA-binding proteins: the
runt homology domain is required for DNA binding and
protein-protein interactions. Mol. Cell. Biol. 13:6336–6345.
17. Look, A.T. 1997. Oncogenic transcription factors in the hu-
man acute leukemias. Science. 278:1059–1064.
18. Okuda, T., J. van Deursen, S.W. Hiebert, G. Grosveld, andT
h
e
 
J
o
u
r
n
a
l
 
o
f
 
E
x
p
e
r
i
m
e
n
t
a
l
 
M
e
d
i
c
i
n
e
61 Komine et al.
J.R. Downing. 1996. AML1, the target of multiple chromo-
somal translocations in human leukemia, is essential for nor-
mal fetal liver hematopoiesis. Cell. 84:321–330.
19. Wang, Q., T. Stacy, M. Binder, M. Marin-Padilla, A.H.
Sharpe, and N.A. Speck. 1996. Disruption of the Cbfa2 gene
causes necrosis and hemorrhaging in the central nervous sys-
tem and blocks definitive hematopoiesis. Proc. Natl. Acad. Sci.
USA. 93:3444–3449.
20. Okada, H., T. Watanabe, M. Niki, H. Takano, N. Chiba, N.
Yanai, K. Tani, H. Hibino, S. Asano, M.L. Mucenski, et al.
1998. AML1( / ) embryos do not express certain hemato-
poiesis-related gene transcripts including those of the PU.1
gene. Oncogene. 17:2287–2293.
21. Ito, Y. 1999. Molecular basis of tissue-specific gene expres-
sion mediated by the runt domain transcription factor
PEBP2/CBF. Genes Cells. 4:685–696.
22. Speck, N.A., T. Stacy, Q. Wang, T. North, T.L. Gu, J.
Miller, M. Binder, and M. Marin-Padilla. 1999. Core-bind-
ing factor: a central player in hematopoiesis and leukemia.
Cancer Res. 59:1789s–1793s.
23. Downing, J.R., M. Higuchi, N. Lenny, and A.E. Yeoh.
2000. Alterations of the AML1 transcription factor in human
leukemia. Semin. Cell Dev. Biol. 11:347–360.
24. Hayashi, K., W. Natsume, T. Watanabe, N. Abe, N. Iwai,
H. Okada, Y. Ito, M. Asano, Y. Iwakura, S. Habu, et al.
2000. Diminution of the AML1 transcription factor function
causes differential effects on the fates of CD4 and CD8 sin-
gle-positive T cells. J. Immunol. 165:6816–6824.
25. Hayashi, K., N. Abe, T. Watanabe, M. Obinata, M. Ito, T.
Sato, S. Habu, and M. Satake. 2001. Overexpression of
AML1 transcription factor drives thymocytes into the CD8
single-positive lineage. J. Immunol. 167:4957–4965.
26. Barner, M., M. Mohrs, F. Brombacher, and M. Kopf. 1998.
Difference between IL-4R alpha-deficient and IL-4-deficient
mice reveal a role for IL-13 in the regulation of Th2 re-
sponses. Curr. Biol. 8:669–672.
27. Fujii, M., K. Hayashi, M. Niki, N. Chiba, K. Meguro, K.
Endo, J. Kameoka, S. Ito, K. Abe, T. Watanabe, and M.
Satake. 1998. Overexpression of AML1 renders a T hybrid-
oma resistant to T cell receptor-mediated apoptosis. Onco-
gene. 17:1813–1820.
28. Bae, S.C., Y. Yamaguchi-Iwai, E. Ogawa, M. Maruyama,
M. Inuzuka, H. Kagoshima, K. Shigesada, M. Satake, and Y.
Ito. 1993. Isolation of PEBP2 B cDNA representing the
mouse homolog of human acute myeloid leukemia gene,
AML1. Oncogene. 8:809–814.
29. Ogawa, E., M. Maruyama, H. Kagoshima, M. Inuzuka, J.
Lu, M. Satake, K. Shigesada, and Y. Ito. 1993. PEBP2/PEA2
represents a family of transcription factors homologous to the
products of the Drosophila runt gene and the human AML1
gene. Proc. Natl. Acad. Sci. USA. 90:6859–6863.
30. Misawa, K., T. Nosaka, S. Morita, A. Kaneko, T. Nakahata,
S. Asano, and T. Kitamura. 2000. A method to identify
cDNAs based on localization of green fluorescent protein fu-
sion products. Proc. Natl. Acad. Sci. USA. 97:3062–3066.
31. Tanaka, Y., T. Watanabe, N. Chiba, M. Niki, and Y.
Kuroiwa, T. Nishihira, S. Satomi, Y. Ito, and M. Satake.
1997. The protooncogene product, PEBP2 /CBF , is
mainly located in the cytoplasm and has an affinity with cy-
toskeletal structures. Oncogene. 15:677–683.
32. Szabo, S.J., S.T. Kim, G.L. Costa, X. Zhang, C.G. Fathman,
and L.H. Glimcher. 2000. A novel transcription factor, T-bet,
directs Th1 lineage commitment. Cell. 100:655–669.
33. Kanno, T., Y. Kanno, L.F. Chen, E. Ogawa, W.Y. Kim, and
Y. Ito. 1998. Intrinsic transcriptional activation-inhibition
domains of the polyomavirus enhancer binding protein
2/core binding factor   subunit revealed in the presence of
the   subunit. Mol. Cell. Biol. 18:2444–2454.
34. Murphy, K.M., W. Ouyang, J.D. Farrar, J. Yang, S. Ranga-
nath, H. Asnagli, M. Afkarian, and T.L. Murphy. 2000. Sig-
naling and transcription in T helper development. Annu. Rev.
Immunol. 18:451–494.
35. Miaw, S.C., A. Choi, E. Yu, H. Kishikawa, and I.C. Ho.
2000. ROG, repressor of GATA, regulates the expression of
cytokine genes. Immunity. 12:323–333.
36. Zhou, M., W. Ouyang, Q. Gong, S.G. Katz, J.M. White,
S.H. Orkin, and K.M. Murphy. 2001. Friend of GATA-1 re-
presses GATA-3–dependent activity in CD4  T cells. J.
Exp. Med. 194:1461–1471.
37. Takahashi, A., M. Satake, Y. Yamaguchi-Iwai, S.C. Bae, J.
Lu, M. Maruyama, Y.W. Zhang, H. Oka, N. Arai, K. Arai,
et al. 1995. Positive and negative regulation of granulocyte-
macrophage colony-stimulating factor promoter activity by
AML1-related transcription factor, PEBP2. Blood. 86:607–
616.
38. Uchida, H., J. Zhang, and S.D. Nimer. 1997. AML1A and
AML1B can transactivate the human IL-3 promoter. J. Immu-
nol. 158:2251–2258.
39. Bae, S.C., E. Ogawa, M. Maruyama, H. Oka, M. Satake, K.
Shigesada, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, and
Y. Ito. 1994. PEBP2 B/mouse AML1 consists of multiple
isoforms that possess differential transactivation potentials.
Mol. Cell. Biol. 14:3242–3252.
40. Halle, J.P., P. Haus-Seuffert, C. Woltering, G. Stelzer, and
M. Meisterernst. 1997. A conserved tissue-specific structure
at a human T-cell receptor  -chain core promoter. Mol. Cell.
Biol. 17:4220–4229.
41. Kitabayashi, I., A. Yokoyama, K. Shimizu, and M. Ohki.
1998. Interaction and functional cooperation of the leuke-
mia-associated factors AML1 and p300 in myeloid cell differ-
entiation. EMBO J. 17:2994–3004.
42. Lutterbach, B., J.J. Westendorf, B. Linggi, S. Isaac, E. Seto,
and S.W. Hiebert. 2000. A mechanism of repression by acute
myeloid leukemia-1, the target of multiple chromosomal
translocations in acute leukemia. J. Biol. Chem. 275:651–656.
43. Aronson, B.D., A.L. Fisher, K. Blechman, M. Caudy, and
J.P. Gergen. 1997. Groucho-dependent and -independent
repression activities of Runt domain proteins. Mol. Cell. Biol.
17:5581–5587.
44. Levanon, D., R.E. Goldstein, Y. Bernstein, H. Tang, D.
Goldenberg, S. Stifani, Z. Paroush, and Y. Groner. 1998.
Transcriptional repression by AML1 and LEF-1 is mediated
by the TLE/Groucho corepressors. Proc. Natl. Acad. Sci.
USA. 95:11590–11595.
45. Kimura, M., Y. Koseki, M. Yamashita, N. Watanabe, C.
Shimizu, T. Katsumoto, T. Kitamura, M. Taniguchi, H. Ko-
seki, and T. Nakayama. 2001. Regulation of Th2 cell differ-
entiation by mel-18, a mammalian polycomb group gene.
Immunity. 15:275–287.
46. Das, J., C.H. Chen, L. Yang, L. Cohn, P. Ray, and A. Ray.
2001. A critical role for NF- B in GATA3 expression and
TH2 differentiation in allergic airway inflammation. Nat. Im-
munol. 2:45–50.